Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Evaluation of a Next-Generation FVIII Mimetic Antibody, Mim8, in Combination with Recombinant FVIIa, FVIII and Activated Prothrombin Complex Concentrate

Laurent Burnier, PhD, Mette B Hermit, PhD, Ida Hilden, Mirella Ezban, PhD, Stine L Kjellev, PhDDVM

Blood (2019) 134 (Supplement_1): 2388.

https://doi.org/10.1182/blood-2019-123340

Published: 2019

Journal Articles

Novel R41Q-PAR1-Modified Mice Enable Proof-of-Concept Studies for in Vivo Mechanisms of Action for Thrombin (IIa) and Activated Protein C (APC)

Ranjeet Kumar Sinha, PhD, Laurent Burnier, PhD, Naveen Gupta, MD, Xiao Xu, MS, Sergey Kupriyanov, PhD, Greg Martin, MS, Laurent O. Mosnier, PhD, John H. Griffin, PhD

Blood (2014) 124 (21): 99.

https://doi.org/10.1182/blood.V124.21.99.99

Published: 2014

Journal Articles

An Engineered Factor Fva Prevents Bleeding Induced By Anticoagulant Wild Type Activated Protein C

Annette Von Drygalski, MD, PharmD, Andrew J. Gale, PhD, Laurent Burnier, PhD, Thomas J. Cramer, PhD, John H. Griffin, PhD, Laurent O. Mosnier, PhD

Blood (2013) 122 (21): 203.

https://doi.org/10.1182/blood.V122.21.203.203

Published: 2013

Journal Articles

In Vitro and in Vivo Neutralization of Murine Activated Protein C

Laurent Burnier, PhD, Jose A. Fernandez, MD, PhD, John H. Griffin, PhD

Blood (2012) 120 (21): 3364.

https://doi.org/10.1182/blood.V120.21.3364.3364

Published: 2012

Journal Articles

Protection Against Vascular Leakage in Vivo by a Peptide Mimetic of the Novel Tethered Ligand Generated by Non-Canonical Cleavage of Protease Activated Receptor 1 by Activated Protein C

Laurent Burnier, PhD, Ranjeet Kumar Sinha, PhD, Eveline A. Bouwens, PhD, John H. Griffin, PhD, Laurent O. Mosnier, PhD

Blood (2012) 120 (21): 497.

https://doi.org/10.1182/blood.V120.21.497.497

Published: 2012

Journal Articles

Insight in Protein S Deficiency From Mouse Models

Sara Calzavarini, PhD, François Saller, PhD, Jose A. Fernandez, MD, PhD, Linda Kadi, PhD, Anne C. Brisset, PhD, Laurent Burnier, PhD, Monica Azevedo, Béatrice Ternon, John H. Griffin, PhD, Anne Angelillo-Scherrer, MD

Blood (2011) 118 (21): 529.

https://doi.org/10.1182/blood.V118.21.529.529

Published: 2011

NARROW

Evaluation of a Next-Generation FVIII Mimetic Antibody, Mim8, in Combination with Recombinant FVIIa, FVIII and Activated Prothrombin Complex Concentrate

Novel R41Q-PAR1-Modified Mice Enable Proof-of-Concept Studies for in Vivo Mechanisms of Action for Thrombin (IIa) and Activated Protein C (APC)

An Engineered Factor Fva Prevents Bleeding Induced By Anticoagulant Wild Type Activated Protein C

In Vitro and in Vivo Neutralization of Murine Activated Protein C

Protection Against Vascular Leakage in Vivo by a Peptide Mimetic of the Novel Tethered Ligand Generated by Non-Canonical Cleavage of Protease Activated Receptor 1 by Activated Protein C

Insight in Protein S Deficiency From Mouse Models

Email alerts

ASH Publications

American Society of Hematology

Evaluation of a Next-Generation FVIII Mimetic Antibody, Mim8, in Combination with Recombinant FVIIa, FVIII and Activated Prothrombin Complex Concentrate

Novel R41Q-PAR1-Modified Mice Enable Proof-of-Concept Studies for in Vivo Mechanisms of Action for Thrombin (IIa) and Activated Protein C (APC)

An Engineered Factor Fva Prevents Bleeding Induced By Anticoagulant Wild Type Activated Protein C

In Vitro and in Vivo Neutralization of Murine Activated Protein C

Protection Against Vascular Leakage in Vivo by a Peptide Mimetic of the Novel Tethered Ligand Generated by Non-Canonical Cleavage of Protease Activated Receptor 1 by Activated Protein C

Insight in Protein S Deficiency From Mouse Models

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only